ASDs Flashcards
List the voltage gated Na+ Channel Blockers
Phenytoin, Fosphenytoin Carbamazepine, Oxcarbazepine Valproic Acid Lamotrigine Topiramate Zonisamide Lacosamine
Which state is are the Na+ channels blocked during
Inactivated state
Phenytoin (Dilantin)
Indication
Focal seizures
Generalized tonic-clonic seizures
Phenytoin (Dilantin)
PK
Non-linear
- With change in dose, t1/2 changes
- Induces metabolic enzymes, different time to steady state based on dose
t 1/2 15-20 hrs
Phenytoin (Dilantin)
Metabolism
CYP2C9/19
Forms: Arene Oxide Active metabolite with ADRs
Phenytoin ADRs
Nystagmus Diplopia Sedation Gingival Hyperplasia** Hirsutism**
Long term:
Choreoathetosis, peripheral neuropathy
Severe:
Toxic epidermal necrolysis
SJS
**Common
Phenytoin (Dilantin)
Teratogenicity
Fetal Hydantoin Syndrome
Phenytoin (Dilantin)
DDIs
-High Plasma Protein Binding (Displacement issues)
-CYP2C9/19 inhibitors
(Cimetidine, Isoniazid, Sulfonamides, Valproic Acid)
-CYP2C9/19 Inducers
(Barbiturates, ChronicEtOH, Carbamazepine, Rifampin)
-Drugs that decrease absorption (Antacids)
-Phenytoin induces CYP3A4, CYP2C, CYP2D
Carbamazepine (Tegretol, Carbatrol)
MOA
Na+ channel blocker
Phenytoin (Dilantin)
MOA
Voltage dependent Na+ channel blocker
Carbamazepine (Tegretol, Carbatrol)
PK: t1/2 and metabolism
t 1/2: 12-30 h (~15 for long term)
Metabolized by CYP3A4 (auto induction), CYP2C9/19
Carbamazepine (Tegretol, Carbatrol)
Indication
- All seizure types except absence seizures
- Temperal lobe epilepsy
Carbamazepine (Tegretol, Carbatrol)
ADRs
BBW, Dose Related, Dose Unrelated, and Long-term Use
BBW: Leukopenia
Dose related: Fatigue, sedation Nystagmus Dilopia Nausea Ataxia
Dose Unrelated:
Rash & SJS
Teratogenicity
Longterm:
Seizure freq. increased
Aplastic anemia
Hypersensitivity
Carbamazepine (Tegretol, Carbatrol)
DDIs
-Strong CYP3A4 inducer
Other ASDs, Oral Contraceptives, Warfarin, Corticosteroids.
-CYP3A4 inhibitors
Valproate, Cimetidine, Erythromycin
-CYP3A4 inducers
Phenytoin, Carbamazepine, primidone, phenobarbital, Ethosuximide
Oxcarbazepine (Trileptal)
MOA and Indication
Same as Carbamazepine
Oxcarbazepine (Trileptal) PK t1/2 t1/2 metabolites Elimination
Oxcarbazepine : 1-2 h
Active metabolites : 8-12 h
Glucuronide (Urinary)
Oxcarbazepine (Trileptal)
ADRs
Dose related
Dose un-related
Less common, less severe
Dose related: Somnolence, dilopia, ataxia
Dose-unrelated: Rash, hyponatremia
Oxcarbazepine (Trileptal)
DDIs
WeakCYP3A4 induction:
Less affected by CYP3A4 modulation
Valproic Acid (Depakote, Depakene) MOAs (3)
- Na channel blocker
- Stimulates GABA synthesis
- Inhibits GABA transaminase
Valproic Acid (Depakote, Depakene) Indication
Most seizure types INCLUDING absence seizures
Lamotrigine (Lamictal)
MOA
Na+ Channel Blocker
Lamotrigine (Lamictal)
Indication
All seizure types
Generalized seizures in children with absence attacks
Lamotrigine (Lamictal)
PK
t1/2
Elimination
25 h
Glucuronide conjugation
Lamotrigine (Lamictal)
ADRs
Headache, nausea, vomiting
Rash (SJS)
Lamotrigine (Lamictal)
DDIs
Hepatic inducers increase glucuronidation (Clearance)
Topiramate (Topamax)
MOAs (3)
- Na+ blocker
- Augments GABA at GABAaR
- Blockatde of Glutamate receptors (Kainate, AMPA)
Topiramate (Topamax)
Indications
Focal Seizures
Generalized tonic-clonic seizures
Topiramate (Topamax)
PK
t1/2
20-30 h
Topiramate (Topamax)
ADRs
Sedation, cognitive slowing, confusion
Fetal malformations
Topiramate (Topamax)
DDIs
Carbamazepine, Phenytoin increase topiramate metabolism
Zonisamide (Zonegran)
MOAs (2)
Na+ channel blocker
T-type Ca2+ channel blocker